ArticleInvestigational new drugs2018

Drug approval based on randomized phase 3 trials for relapsed malignancy: analysis of oncologic drugs granted accelerated approval, publications and clinical trial databases.

Sumimasa Nagai et al.PubMed ↗Publisher ↗

No numbers read from the abstract.